Triple-Negative Breast Cancer heterogeneity: extracellular matrix, immune evasion, and therapeutic resistance landscape
Clinical Breast Cancer · 2026-10
DOI: 10.1016/j.clbc.2026.10.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Breast Cancer, 2026-10. Verfasst von Maysa Coelho Vieira-Costa und 2 weiteren Autor:innen. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordination for the improvement of Higher Education Personnel, State of Sao Paulo Research Foundation, National Council for Scientific and Technological Development.
Abstract (Originalsprache)
Triple-negative breast cancer is the most aggressive breast cancer subtype, showing high molecular heterogeneity, extracellular matrix remodeling, and distinct immune evasion, all of which contribute to therapeutic resistance. This review discusses current evidence on the interplay between the tumor microenvironment, extracellular matrix, and immune checkpoint regulation in triple-negative breast cancer progression. We summarize how matrix remodeling, cancer-associated fibroblasts, and biomechanical signaling promote immune suppression by limiting cytotoxic immune cell infiltration and modulating PD-1/PD-L1 and CTLA-4 pathways. We also discuss how these interactions reduce the efficacy of chemotherapy and immunotherapy while highlighting emerging therapeutic approaches targeting both stromal and immune components, including nanomedicine and mRNA-based strategies. A better understanding of the reciprocal interactions between the extracellular matrix and the immune microenvironment may support the development of more effective therapeutic strategies and improve clinical outcomes for patients with triple-negative breast cancer.
Förderung
- Coordination for the improvement of Higher Education Personnel
- State of Sao Paulo Research Foundation
- National Council for Scientific and Technological Development
Zitieren
APA
Vieira-Costa, M. C., Júnior, L. T., & Sogayar, M. C. (2026). Triple-Negative Breast Cancer heterogeneity: extracellular matrix, immune evasion, and therapeutic resistance landscape. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2026.10.016
Vancouver
Vieira-Costa MC, Júnior LT, Sogayar MC. Triple-Negative Breast Cancer heterogeneity: extracellular matrix, immune evasion, and therapeutic resistance landscape. Clinical Breast Cancer. 2026. doi:10.1016/j.clbc.2026.10.016
BibTeX
@article{VieiraCosta2026,
author = {Vieira-Costa, Maysa Coelho and Júnior, Leandro Teodoro and Sogayar, Mari Cleide},
title = {Triple-Negative Breast Cancer heterogeneity: extracellular matrix, immune evasion, and therapeutic resistance landscape},
journal = {Clinical Breast Cancer},
year = {2026},
doi = {10.1016/j.clbc.2026.10.016}
}
EUVIMED